Tower Research Capital LLC (TRC) - FENNEC PHARMACEUTICALS INC ownership

FENNEC PHARMACEUTICALS INC's ticker is FENC and the CUSIP is 31447P100. A total of 31 filers reported holding FENNEC PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.89 and the average weighting 0.3%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of FENNEC PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$11,040
+99.7%
1,470
+134.8%
0.00%
Q2 2023$5,527
+21157.7%
626
-79.9%
0.00%
-100.0%
Q1 2023$26
-10.3%
3,118
+0.8%
0.00%0.0%
Q4 2022$29
-99.9%
3,092
-14.4%
0.00%
Q3 2022$29,000
+26.1%
3,611
-9.2%
0.00%
-100.0%
Q2 2022$23,000
+2200.0%
3,977
+2781.9%
0.00%
Q1 2022$1,000
-96.2%
138
-97.7%
0.00%
Q4 2021$26,000
-16.1%
5,970
+17.6%
0.00%
-100.0%
Q1 2021$31,000
-13.9%
5,075
+4.2%
0.00%0.0%
Q4 2020$36,000
-71.4%
4,870
-76.6%
0.00%0.0%
Q3 2020$126,000
+1160.0%
20,807
+1669.3%
0.00%
Q2 2020$10,000
+42.9%
1,176
+1.1%
0.00%
-100.0%
Q4 2019$7,000
+250.0%
1,163
+183.7%
0.00%
Q3 2019$2,000
-88.2%
410
-88.3%
0.00%
-100.0%
Q1 2019$17,000
+466.7%
3,512
+1029.3%
0.00%
Q3 2018$3,000
+200.0%
311
+279.3%
0.00%
Q1 2018$1,000
-92.9%
82
-92.5%
0.00%
-100.0%
Q4 2017$14,000
+250.0%
1,091
+172.8%
0.00%
Q3 2017$4,0004000.00%
Other shareholders
FENNEC PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Sonic Fund II, L.P. 2,433,230$18,128,0008.76%
Solas Capital Management, LLC 800,000$5,960,0004.55%
Southpoint Capital Advisors LP 4,077,214$30,375,0000.53%
683 Capital Management, LLC 1,110,000$8,269,0000.39%
VALLEY FORGE INVESTMENT CONSULTANTS INC ADV 40,000$298,0000.26%
Avoro Capital Advisors LLC 1,670,000$12,442,0000.21%
Eventide Asset Management 1,120,000$8,344,0000.13%
Hartford Financial Management Inc. 38,848$289,0000.08%
Granahan Investment Management 394,810$2,941,0000.07%
Planned Solutions, Inc. 800$6,0000.01%
View complete list of FENNEC PHARMACEUTICALS INC shareholders